Amgen, Inc. (AMGN)
481.40
+20.14
(+4.37%)
USD |
NASDAQ |
Nov 04, 15:21
Amgen Total Return Price : 481.40 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 461.26 |
| November 02, 2026 | 465.45 |
| October 30, 2026 | 466.01 |
| October 29, 2026 | 460.73 |
| October 28, 2026 | 451.83 |
| October 27, 2026 | 447.95 |
| October 26, 2026 | 444.63 |
| October 23, 2026 | 439.26 |
| October 22, 2026 | 447.28 |
| October 21, 2026 | 438.34 |
| October 20, 2026 | 438.94 |
| October 19, 2026 | 424.94 |
| October 16, 2026 | 432.49 |
| October 15, 2026 | 434.03 |
| October 14, 2026 | 426.11 |
| October 13, 2026 | 412.84 |
| October 12, 2026 | 417.57 |
| October 09, 2026 | 414.87 |
| October 08, 2026 | 407.44 |
| October 07, 2026 | 413.08 |
| October 06, 2026 | 402.60 |
| October 05, 2026 | 402.98 |
| October 02, 2026 | 403.04 |
| October 01, 2026 | 407.27 |
| September 30, 2026 | 421.51 |
| Date | Value |
|---|---|
| September 29, 2026 | 423.64 |
| September 28, 2026 | 418.13 |
| September 25, 2026 | 414.61 |
| September 24, 2026 | 406.04 |
| September 23, 2026 | 406.09 |
| September 22, 2026 | 410.24 |
| September 21, 2026 | 393.16 |
| September 18, 2026 | 385.65 |
| September 17, 2026 | 379.78 |
| September 16, 2026 | 376.35 |
| September 15, 2026 | 375.65 |
| September 14, 2026 | 381.50 |
| September 11, 2026 | 377.35 |
| September 10, 2026 | 382.47 |
| September 09, 2026 | 391.27 |
| September 08, 2026 | 393.17 |
| September 04, 2026 | 437.23 |
| September 03, 2026 | 444.12 |
| September 02, 2026 | 442.84 |
| September 01, 2026 | 438.12 |
| August 31, 2026 | 429.88 |
| August 28, 2026 | 432.42 |
| August 27, 2026 | 436.99 |
| August 26, 2026 | 440.34 |
| August 25, 2026 | 442.24 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Gilead Sciences, Inc. | 174.94 |
| Regeneron Pharmaceuticals, Inc. | 940.98 |
| AbbVie, Inc. | 292.48 |
| Biogen, Inc. | 253.15 |
| Vertex Pharmaceuticals, Inc. | 546.88 |